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Role of inhibition of atrial natriuretic factor release in the down-
regulation of salt excretion. We investigated the role of atrial natriuretic
factor (ANF) in the down-regulation of sodium excretion (UNaV).
Seven subjects were sequentially studied while injesting a normal-salt
diet (220 mmol NaCI/day, NSD), a very low-salt diet (20 mmol
NaCI/day, VLSD) for six days, and again at NSD for nine days. After
one day of VLSD, a negative salt balance of 85 mmol was achieved and
plasma ANF decreased from 19.1 (SE 2.5) to7.2 (sa 2.1) pg/mi, whereas
plasma renin activity (PRA) and plasma aidosterone (ALD) increased
after the third and second day, respectively. During restoration of
volemia (NSD), ANF increased after the third day; in contrast, PRA
and ALD decreased earlier. Seven other subjects kept at low-salt diet
(50 mmol NaCI/day) were studied during ANF infusion (at 2, 4, 8
ng/min/kg body wt). Increases of ANF from 10.3 (SE 0.9) pg/mI (basal
condition) to levels of 24.0 (SE 1.9) pg/mI (infusion study), occurring
physiologically in the same subjects after NSD, evoked increases in
UNaV that accounted for 62% of UNaV rise necessary to balance the
NSD, whereas PRA or ALD did not change. Plasma ANF, unlike PRA
or ALD, was directly correlated with UNaV. In conclusion: (a) ANF
changes earlier than PRA and plasma aldosterone during VLSD; (b)
PRA and ALD respond more promptly than ANF in the recovery from
hypovolemia; (c) during ingestion of a low-salt diet, changes in plasma
ANF by infusion account for more than half the increase in UNaY
following the shift from low- to normal-salt diet independently of
alterations in PRA and ALD.
Until now the interest in ANF as a physiologic regulator of
salt and volume homeostasis has been mainly focused on the
release of this hormone related to manuevers, such as increased
salt intake [1—9], head-out water immersion [10] and ventricu-
loatrial pacing [11], that induce positive salt balance or volume
expansion. Under those conditions, the increase in plasma
ANF, elicited by atrial distension [12], stimulates urinary
excretion of sodium and water, thereby reducing intravascular
volume and atrial pressure toward normal levels.
It is also relevant, however, to assess whether and to what
extent changes in plasma ANF levels contribute to maintain salt
and volume balance during salt depletion, Previous reports [1,
3—9, 13] have studied the behavior of ANF after shifting healthy
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subjects from normal to low-salt diets. In all these studies,
however, the level of salt intake preceding the low-salt period
was not carefully defined. The methodological limits of these
studies may account for the discrepancies in the data obtained
when healthy subjects were shifted from a normal- to a low-salt
diet. Indeed, some authors [7—9] did not find any significant
difference between plasma ANF levels during normal- and
low-sodium diet; in contrast, others [4—6] found a significant
decrease in plasma ANF after low-sodium diet. In absolute
terms, in the study of Shirataka et a!. [7], a negative sodium
balance of 84 mmol after seven days did not modify plasma
ANF, whereas Richards et a! [3] have shown that a sodium
depletion averaging 70 to 80 mmol was sufficient to reduce
plasma ANF concentrations after three days of low-sodium
diet.
On the other hand, similar discrepancies arise when consid-
ering to what extent the increased levels of ANF contribute to
enhance urinary excretion of sodium; indeed, some studies
suggest ANF infusion is not particularly potent as a natriuretic
agent in humans [14]. In contrast, we have recently demon-
strated that when plasma ANF is experimentally increased—
with replacement of salt urinary losses—in normal subjects to
the levels that the same subjects gain on very-high-salt diet (400
mmol/day), this hormone is one of the major contributors in
up-regulating salt excretion [2].
The aim of the present study was to gain further insight into
the physiological role of ANF in the down-regulation of salt
excretion. Therefore, we compare the changes in UNaV with
the adjustments of ANF and the renin-aldosterone axis, the
most important "volume sensing" hormones [15], in subjects
undergoing chronic manipulation of salt diet from normal- to
low-salt intake (long-term study) and during acute infusion of
human alfa-ANF in the salt-depleted state (acute study).
Methods
Subjects
Fourteen normotensive male volunteers of our medical staff,
aged 26 to 34 years, were studied after giving their informed
consent for the study. All of them had a negative history for
hypertension, cardiovascular disease, and diabetes. Clinically-
apparent renal disease was excluded in all the subjects, by
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documented normal urinalysis and creatinine clearance greater
than 120 mllmin. Throughout the study, subjects were allowed
to perform their normal activities but they were discouraged
from vigorous exercise. The subjects were taking no medica-
tions for at least one month before the study and during the
whole period of the study.
Long-term study
Seven subjects were initially studied at their usual diet for
seven consecutive days by daily 24-hour urine collections.
Under such condition of free diet, urinary sodium excretion
averaged 220 (11 SE) mmol/day; on the basis of this result, we
decided to evaluate each subject on a daily diet (35 kCal/kg of
body wt) containing a fixed NaCl intake of 20 mmol supple-
mented with 200 mmol of NaCI (normal-salt diet). Urinary salt
excretion was measured daily, and a blood sample was col-
lected for three days after a state of salt balance (daily urinary
Na excretion ranging between 210 and 230 mmol in each
subject) was achieved and maintained for at least three consec-
utive days. The subjects were then shifted to a diet (35 kCal/kg
of body wt) containing only 20 mmol NaCI for six days
(very-low-salt diet). Thereafter, the subjects were again studied
during nine days of normal salt diet.
Each morning (8 a.m.), the subjects, fasting, were visited at
our Unit. Body weight was recorded after voiding, the subjects
wearing the same indoor clothing and no shoes. Blood pressure
(BP) and pulse rate were registered on the same arm as the
mean of three consecutive measurements with the subject in
sitting position. Then, a blood sample was drawn from the
antecubital vein after resting in the sitting position for 10 to 15
minutes. The use of alcohol, tobacco, tea and coffee was
allowed only after taking the blood sample.
BP was measured with a mercury sphygmomanometer, tak-
ing the fifth Korotkoff sound as diastolic value. ANF, plasma
renin activity (PRA), aldosterone (ALD), sodium, potassium,
total protein, and creatinine were measured in blood samples.
Sodium, potassium, and creatinine were measured in urine.
Acute study
Seven subjects started a diet containing 50 mmol NaCI/day
(low-salt diet). Urinary salt excretion was measured daily, and
the studies were performed after a state of salt balance was
maintained for three consecutive days (that is, urinary salt
excretion ranged from 45 to 55 mmol/day). On the morning (8
a.m.) of day 4, a venous cannula was inserted in each arm, and
three consecutive basal studies were performed. These studies
consisted of timed (30 mm) urine collections immediately pre-
ceded and followed by blood sampling. Then, stepwise infusion
of progressively higher doses of human alfa-ANF (Novabio-
chem, Switzerland) was administered. The infusion rates were
2, 4, 8 ng/minlkg of body weight. Each step lasted 60 minutes,
and was divided into two 30-minute periods, at the start and end
of which blood and urine were collected as in basal periods.
ANF, PRA, ALD, creatinine, Na and K were measured in
the blood sample; creatinine, Na and K were measured in
urine. BP and pulse rate were measured every 10 minutes
throughout the study. During infusion of ANF, the urinary fluid
losses were replaced by infusing equal volumes of hypotonic
saline (80 mmol/liter) in the controlateral arm.
The subjects were then shifted to a diet containing 220 mmol
NaCI/day (normal-salt diet). After the state of salt balance was
gained and maintained for three consecutive days (that is, daily
urinary NaCl excretion ranged from 210 to 230 mmol), three
basal studies were performed on the morning of day 4 as
previously described. ANF infusion studies were not repeated
in the normal-salt diet condition.
Analytical determinations
PRA and plasma ALD were measured by radioimmunoassay
with commercial kits (Sorin, Saluggia, Italy). Sodium and
potassium were measured in plasma and urine by flame pho-
tometry. Creatinine was measured by a Technicon AutoAna-
lyzer. Serum protein concentration was measured by the biuret
method. Blood samples (7 ml) for ANF radioimmunoassay were
collected in chilled polystyrene tubes containing 0.3 ml of 10%
EDTA and then immediately centrifuged at 4°C. Plasma was
separated and stored at —20°C. Aliquots of plasma (2.5 ml) were
added to iodinated ANF [1,200 counts per miii (cpm)] and
purified through C 18 Sep-Pak cartridges prepared by previous
washing with pure acetonitrile (2 ml) followed by distilled water
(8 ml). After addition of plasma, Sep-Pak cartridges were
sequentially washed with distilled water (3 ml), 0.1 trifluoroace-
tic acid (3 ml), and a 10% solution of acetonitrile in trifluoro-
acetic acid. Plasma ANF was eluted in 6 ml of 80% acetonitrile,
then dried by evaporation and lyophilized. The lyophilized
samples were dissolved in 0.35 ml of a 0.1 M buffer phosphate
solution (pH 7.4) containing sodium azide (0.1%), Triton X-lOO
(0.1%), and bovine serum albumin (BSA, 0.5%). A 0.1 ml
aliquot of the reconstituted samples was used to calculate
recovery of 125j labeled ANF. Radioimmunoassay was per-
formed in duplicate by mixing 0.1 ml of anti-ANF antiserum
(Novabiochem, Switzerland). After 24 hours of incubation at
4°C, 0.1 ml of '251-ANF (8,000 cpm) was added and left for a
further 24 hours at 4°C. Finally, 1 ml of dextran charcoal in
buffer was added, the samples were centrifuged at 4°C, and the
supernatant was counted. The least detectable concentration
was 0.3 pg/tube, which corresponded to 0.7 pg/mi of plasma for
the volume extraction used. The intra-assay and interassay
variation coefficients were 3.5 and 3.7%, respectively. Recov-
ery of ANF was 61 0.02% (SE); recoveries in individual
samples were determined by addition of 1251-ANF (1,200 cpm)
to the plasma before extraction. All plasma levels of ANF were
calculated after correction for single recovery.
Statistics
Comparison of the means by analysis of variance for repeated
measurements with Bonferroni test, linear regression analysis,
and multiple regression analysis were performed using the
BMDP statistical software [161. Differences with P < 0.05 were
considered significant.
Results
Long-term study
Sodium balance. During normal salt intake (220 mmol/day of
NaCl), the single values of daily urinary NaCl excretion were
210 to 230 mmol/day for at least three days in each subject.
Therefore, the condition of steady state for sodium balance was
fully documented in each subject.
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The very-low-salt diet (20 mmol per day) induced a progres-
sively decreasing daily sodium balance: 85 in the first day, 43 in
the second day, 37 in the third day and 17 mmol/day in the
fourth day. In the last two days of study (days Sand 6), a neutral
balance of sodium was observed, that is, daily intake of sodium
was similar to its output (Fig. 1). At the end of this period, the
mean cumulative sodium balance was —188 mmol, indicating a
net decrease of 1.3 to 1.4 liters of extracellular volume (Fig. 2).
This finding is in agreement with the mean decrease of body
weight from 76.7 (SE 1.9) to 75.3 (SE 1.8) kg (P < 0.0001). As
expected, plasma protein concentration increased from 7.1 (SE
0.1) to 7.8 (SE 0.1) g/dl.
When salt intake was increased to 220 mmol/day, daily
sodium balance became positive (Fig. 1), particularly in the first
two days when about 165 mmol of salt were retained (132 in the
1st day and 31 in the 2nd day). During the third and fourth days
the sodium balance returned neutral. In the fifth and sixth days
daily sodium output slightly exceeded its intake. Thereafter, the
daily intake slightly exceeded the output: the cumulative bal-
ance of sodium at the end of nine days of regular salt diet was,
therefore, neutral (Fig. 2). As expected, body weight and
plasma protein concentration returned to baseline values, that
is, 76.7 (SE 2.0) kg and 7.1 (SE 0.1) g/dl, respectively.
Plasma levels of ANF. ANF was detectable in all plasma
samples but four. These samples, obtained during very-low-
sodium diet, were included in our statistical analysis as repre-
senting the ANF level at the mean between 0 and the lower limit
of detectability.
As depicted in Figure 3, during the basal normal-salt intake,
mean plasma levels of ANF were stable in all subjects, ranging
from 20 to 18 pg/mI. The very-low-salt intake was associated
with a prompt decrease of plasma ANF to 7.2 (SE 2.1) pg/mi (P
<0.01); after the 1st day, the values of plasma ANF and urinary
NaCI excretion fell in all subjects (Fig. 4). In the following days
plasma ANF levels further decreased, achieving the minimum
mean values (about 3 pg/mI) on days 4, 5 and 6.
After volume depletion, the return to a normal-salt intake
induced a progressive increase of plasma ANF levels; in the
first day, mean plasma ANF level doubled the value of the last
day of the very-low-salt diet; in the second day, it became
significantly greater than in the last day of very-low-salt diet
(but still remaining lower than in the basal period); in the third
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day, there was no statistical difference with the values of the
basal period, and, finally, in the following days, ANF levels
achieved the maximum value, ranging between 22 and 26 pg/mi
(Fig. 3).
PRA and plasma ALD levels. PRA and ALD responses to
very-low-salt diet were parallel and inverse to that of ANF
(Figs. 3, 5). As shown in Figure 5, hypovolemia resulted in
gradual stimulation of PRA. During very-low-salt diet, the
increase in PRA attained statistical significance after the third
day (P < 0.01 compared with basal values). On the contrary,
the recovery from hypovolemia during the normal-salt diet
induced sustained suppression of PRA that promptly decreased
to values statistically not different from baseline after the first
day (Fig. 5).
ALD statistically increased after the second day of the
very-low-salt diet, and returned to basal values after two days
of normal-salt diet (Fig. 3).
Regression analysis of hormonal and renal responses to
hypovolemia (N = 105). Since inclusion of several samples from
each volunteer might influence regression analyses, the inter-
correlations of ANF, PRA, ALD and UNaV levels on different
diets were calculated. No significant correlation between these
levels was found, confirming the independence of the observa-
tions from the same volunteer.
Regression analysis of aldosterone values over the respective
ANF values showed a significant inverse relationship (r =
0.371, P <0.0001; slope, —5.505; intercept, +445.9). Similarly,
PRA values were inversely correlated with the respective ANF
values (r = 0.275, P < 0.005, slope, —0.048; intercept, +2.9).
As depicted in Figure 6, regression analysis of ANF values
over the respective UNaV values showed a highly significant
direct relationship (r = 0.612, P < 0.0001; slope, +0.105;
intercept, —0.144). Similarly, aldosterone values were inversely
correlated with the respective UNaV values (r = 0.462, P <
0.0001; slope, —0.911; intercept, +467.0; Fig. 6) and PRA
values were inversely correlated with the respective UNaV
values (r = 0.490, P <0.0001; slope, —0.014, intercept, +4.010.
Stepwise regression of UNaV over ANF and aldosterone as
independent variables showed that ANF is the first determinant
of UNaV, accounting for 38.4% of the variance of UNaV
(multiple R2, 0.384; F ratio, 60.5; P < 0.0001), while aldoste-
rone accounted for a further 9.4% of variance of UNaV.
Regression analysis of ANF values over the respective cu-
mulative sodium balance values showed a significant direct
relationship (r = 0.348, P < 0.0005; slope, +3.628; intercept,
—7.4). Similarly, aldosterone values were inversely correlated
with the respective cumulative sodium balance values (r =
—0.477, P < 0.0001; slope, —0.332; intercept, +161.9).
Systemic and renal parameters. The average values of sys-
tolic and diastolic blood pressure (BP) and the pulse rate in
basal conditions were 119 (SE 3) mm Hg, 83 (SE 2) mm Hg and
81 (SE 3) beats/mm, respectively. These values did not vary
after changing diet. In basal conditions, creatinine clearance
and urinary potassium excretion were 139 (Sn 11) mllmin/1 .73
m2 and 42 (SE 3) mmollday, respectively, and did not change
significantly throughout the study.
Acute study
During the low-salt diet plasma ANF averaged 10.3 (SE 0.9)
pg/mi. Stepwise infusion of ANF increased significantly plasma
ANF; the average values at progressively higher doses (2, 4, 8
ng ANF/min/kg body wt) were 30.1 (SE 4.2), 56.3 (SE 6.5)and
72.8 (SE 7.4) pg/mI, respectively. Mean plasma ANF after
normal-salt diet was 24.0 (SE 1.3) pg/mi, a value significantly
higher than the preinfusion value at low-salt diet, and not
significantly different from that gained during the first infusion
at 2 ng/min/kg.
Basal UNaY at low-salt diet averaged 0.035 (SE 0.002) mEq/
mm. Stepwise infusion of ANF increased significantly UNaV;
the average values at progressively higher doses were 0.132 (SE
0.008), 0.188 (SE 0.011) and 0.272 (SE 0.019). During the normal-
salt diet, UNaV averaged 0.153 (SE 0.007) mEq/min.
The preinfusion values of PRA and aldosterone during the
low-salt diet were significantly higher than at normal-salt diet
[2.7 (SE 0.3) ng/ml/hr vs. 1.4 (sn 0.2) ng/ml/hr (P < 0.01) and
268.6 (SE 7.0) pg/mI vs. 217.1 (SE 10.2) pg/ml (P < 0.05),
respectively]. The average values of PRA and aldosterone at
progressively higher doses of ANF infusion were 2.3 (SE 0.3),
2.1 (SE 0.3), 1.9 (SE 0.2) ng/mI/hr and 239.8 (SE 9.1), 226.7 (SE
9.3), and 201.6 (SE 6.2) pg/mI, respectively. Only the average
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first day of low salt diet in the same subjects.
Points represent single subjects.
values of PRA and plasma aldosterone, obtained at the highest
dose of ANF (8 ng/min/kg body wt), were significantly lower
than those observed before ANF infusion at low-salt diet (P <
0.05).
In each subject we selected the value of plasma ANF that, in
a single 30-minute collection period during infusion of ANF,
was the closest to the value observed at normal-salt diet. Under
such conditions, plasma ANF averaged 24.0 (SE 1.9) pglml
during infusion and 24.0 (SE 1.3) pg/mI during the normal-salt
diet; plasma aldosterone averaged 247.1 (SE 8.1) pg/mI during
infusion and 217.1 (SE 10.2) pglml during the normal-salt diet
(NS); UNaV averaged 0.108 (SE 0.006) mEq/min during infusion
and 0.153 (SE 0.007) mEq/min during the normal-salt diet (P <
0.001; Fig. 7).
In the low-sodium diet condition, before and after ANF
infusion the values of plasma ANF and UNaV were directly and
highly correlated (r = 0.825, P < 0.0001; slope, +1.108;
intercept, +4.762), whereas the values of PRA or plasma
aldosterone over the respective UNaV values were not signifi-
cantly correlated.
The average basal values of systolic and diastolic BP and the
pulse rate during low-salt diet were 117 (SE 3) mm Hg, 82 (SE 2)
mm Hg and 82 (SE 3) beats/mm, respectively, and did not vary
during ANF infusion. Creatinine clearance and urinary potas-
sium excretion were 136 (SE 12) ml/minll.73 m2 and 41 (SE 3)
mmollday, respectively, and did not change throughout infusion
of different doses of ANF. Serum protein concentration aver-
aged 7.0 (SE 0.1) g/dl before infusion and remained unchanged
throughout the infusion time. The increase in salt intake from
low to normal salt diet was associated to a rise in the mean body
weight from 77.1 (SE 1.9) kg to 80.0 (SE 1.9) kg (P < 0.01).
Discussion
To evaluate the sensitivity of ANF response to salt depletion,
it is crucial to examine the first days following sodium restric-
tion, that is, before a neutral balance of sodium is achieved. The
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data available in literature are inadequate to answer this ques-
tion. Indeed, in most studies [1—4, 6, 8, 9, 13] plasma ANF was
measured only at the end of the low-salt diet (that is, after 3 or
12 days).
Furthermore, a neutral balance between daily NaCl intake
and its output is achieved after few days and the renal response
to ANF mainly depends on the baseline sodium and the volume
status [17]. In all the previous studies [1, 3—9, 13], however, the
mean of the values of a single determination of dialy UNaV was
assumed to be representative of the daily salt intake for all
subjects.
In our long-term study, the compliance to a fixed basal intake
of salt was ascertained in every single subject by repeated and
consecutive measurements of daily urinary excretion of NaC1;
sodium balance and ANF levels were evaluated since the first
day of low-salt diet. After 24 hours of low sodium diet, a
negative balance of 85 mmol of salt, equivalent to 0.6 liter of
depletion in extracellular volume (approximately —5%), was
associated with a marked decrease in plasma ANF (—250%) in
absence of changes in PRA and plasma aldosterone, demon-
strating that ANF release is suppressed by small percent
reductions in extracellular volume, and that plasma ANF
changes earlier than PRA and plasma aldosterone after shifting
subjects from the normal- to the low-salt diet. In the following
days of sodium deprivation, ANF further decreased, achieving
on the fourth day the minimum mean value (about 3 pg/ml),
which was maintained in the following two days of low-sodium
diet when the salt balance was neutral. Interestingly, ANF was
detectable in almost all plasma samples despite the prolonged
low sodium intake, and the progressive reduction in the extra-
cellular volume rose to a final volume of 10%.
The dynamic adjustments of plasma ANF tracked the fluctu-
ations in daily sodium balance and were highly and directly
correlated to daily UNaV values (Fig. 6). Indeed, our plasma
ANF levels were strongly influenced by modifications of UNaV
ranging from 20 to 220 mmolfday. As expected, plasma aldo-
sterone levels were inversely correlated to the daily UNaV
values (Fig. 6). In addition, as suggested by the results of the
multiple regression analysis, ANF and aldosterone, considered
the most important "volume sensing" hormones [15], ac-
counted for almost half of UNaV variance. It is important to
consider that appropriate changes in other hormones, that is,
cathecolamines [18] or intrarenal physical factors [19] may have
contributed to the maintenance of sodium homeostasis during
hypovolemia.
Restoration of a normal extracellular volume was associated
with a prompt inhibition of the renin-aldosterone system and
with a progressive stimulation of ANF. Under those conditions,
plasma aldosterone and PRA changed earlier than ANF levels,
suggesting that renin-aldosterone axis becomes more important
than ANF in order to recover hypovolemia. Taken together, the
findings of the long-term study suggest a role for ANF in the
maintenance of daily sodium balance during chronic alteration
in the setting from normal- to low-salt diet, although a cause-
effect relationship between ANF and UNaV cannot be demon-
strated by the present long-term study.
In the acute study, infusion of ANF during low-salt diet and
alterations of diet from low- to normal-salt intake have been
performed in the same normal volunteers to evaluate whether
and to what extent ANF contributes to the natriuresis neces-
sary to balance the augmented salt intake, that is, from 50
mmoL/day to 220 mmol/day. Infusion studies were performed
during low-salt diet at different rates, ranging from 2 nglminlkg
(the lowest rate of ANF infusion) up to 8 ng!min/kg. We could
select, by infusing ANF in subjects kept on low-salt diet, the
plasma ANF levels (and the corresponding UNaV values) that
were closer to those occurring during normal-salt diet; at such
plasma ANF levels there was a corresponding rise in sodium
excretion of 0.073 mEq/min, that is, 62% of the rise (0.118
mEq/min) evoked by the physiological maneuver. Thus,
changes in plasma ANF, following its infusion, accounted for
more than half the increase in salt excretion that occurred after
modifying salt intake from 50 to 220 mmol NaCl/day. This is the
minimum extent to which ANF contributed to regulate salt
excretion when subjects are switched from low- to normal-salt
diet; indeed, the natriuresis, induced by ANF infusion at
low-salt intake, may have been blunted by some salt-retaining
effects no longer active on the normal-salt diet.
*
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UNaV levels were lower in the basal state of the low-salt diet
than those observed during ANF infusion. The decreased
natriuresis was associated with a relevant reduction of plasma
ANF without any change in plasma volume, as witnessed by the
constancy of serum protein concentration. Under such experi-
mental conditions, a highly significant linear correlation be-
tween plasma ANF and UNaV is demonstrated. More interest-
ingly, the values of PRAand plasma aldosterone did not change
during infusion of ANF and did not correlate with sodium
excretion. Such a finding may suggest that ANF plays a role of
relevance to regulate sodium excretion in the shift from low- to
normal-salt intake independently of changes in the renin-aldo-
sterone axis.
Interestingly, our findings indicate that ANF has relevant
natriuretic effects at much lower plasma concentrations than
those shown in previous studies. In literature, progressive
elevations of ANF 1.5- to 13-fold above control values induced
a relatively modest natriuresis [20—24]. The explanation to such
discrepancies most likely resides in the lack of replacement of
fluid and salt urinary losses following ANF infusion. The
consequent negative salt and fluid balance may have, therefore,
blunted the ANF induced natriuresis.
In conclusion, the present study suggests that: (i) ANF is
suppressed by about 5% reduction in extracellular volume and,
changes earlier than renin-aldosterone axis to down-regulate
sodium excretion during hypovolemia; (ii) the renin-aldosterone
axis is more prompt than ANF in the recovery from hypovo-
lemia; (iii) during the low-salt diet, changes in plasma levels of
ANF by infusion, reproducing the levels obtained at normal-salt
diet, account for more than half the increment in sodium
excretion after switching diet from low- to normal-salt intake.
This natriuretic effect of ANF appears to be unrelated to
alterations of the renin-aldosterone axis.
However, it is important to note that changes in circulating
ANF or aldosterone do not necessarily reflect the hormonal
influence on sodium excretin. Other parameters, in fact, can
interfere: the residence of the target cells to the hormonal
action, the regulation of the receptor density or the hormonal
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Fig. 6A. Linear regression of plasma ANF
vs. UN.,V (r = 0,612, P < 0.0001); B. Linear
regression of plasma aldosterone (ALD) vs.
UN,,V (r = 0.462, P < 0.0001) during salt
intake changes.
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Fig. 7. Urinary sodium excretion (UNV), plasma ANF (Li) and
plasma aldosterone () at low-salt diet before ANF infusion, at similar
levels of plasma ANF during ANF infusion and at normal-salt diet in
same subjects. °P < 0.05 and * < 0.0001 vs. low-salt diet; °°P < 0.001
vs. low-salt diet + ANF infusion.
intrarenal concentration. Further studies will be required to
better define the interaction between ANF and the renin-
aldosterone system in the regulation of salt intake.
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